Outpatient management of severe COPD

New England Journal of Medicine

Volumn 362, Issue 15, 2010, Pages 1407-1416

  Niewoehner, Dennis E ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ARFORMOTEROL; BECLOMETASONE; BUDESONIDE; COTRIMOXAZOLE; FLUTICASONE; FORMOTEROL; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; MACROLIDE; MOMETASONE FUROATE; OXYGEN; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALBUTAMOL; SALMETEROL; TETRACYCLINE DERIVATIVE; THEOPHYLLINE; TIOTROPIUM BROMIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ABNORMAL RESPIRATORY SOUND; AGED; AIRWAY OBSTRUCTION; ARTICLE; AUSCULTATION; BLURRED VISION; BRONCHITIS; BRONCHODILATATION; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL PROTOCOL; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COUGHING; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DYSPHONIA; DYSPNEA; EMERGENCY CARE; FORCED EXPIRATORY VOLUME; HEADACHE; HEART PALPITATION; HUMAN; HYPERSENSITIVITY REACTION; HYPOXEMIA; INSOMNIA; LOW DRUG DOSE; MALE; NAUSEA; OUTPATIENT; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; RHINOPHARYNGITIS; SEIZURE; SMOKING CESSATION; SORE THROAT; SPIROMETRY; TACHYCARDIA; THROAT IRRITATION; THRUSH; TREATMENT INDICATION; TREMOR; URINE RETENTION; VOMITING; XEROSTOMIA; DRUG COMBINATION; HOSPITALIZATION; IMMUNIZATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG FUNCTION TEST; OXYGEN THERAPY; PRACTICE GUIDELINE; REVIEW; SMOKING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; AGED; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; DYSPNEA; HUMANS; IMMUNIZATION; LUNG; MALE; OXYGEN INHALATION THERAPY; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION;

EID: 77950995260     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp0912556     Document Type: Article

References (56)

1. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-360 (Pubitemid 36204553)
2. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-750 (Pubitemid 47321907)
3. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-1259
4. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir Care 2002;47:1184-1199
5. Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest 2001;119:344-352 (Pubitemid 32163742)
6. Balmes J, Becklake M, Blanc P, et al. American Thoracic Society statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003;167:787-797
7. Ezzati M. Indoor air pollution and health in developing countries. Lancet 2005;366:10-46. (Pubitemid 40991197)
8. Holleman DR Jr, Simel DL. Does the clinical examination predict airflow limitation? JAMA 1995;273:31-39.
9. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Update 2009. (Accessed March 19, 2010, at http://www.goldcopd.com.)
10. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-586
11. Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007;131:20-28 (Pubitemid 46122970)
12. Guyatt GH, Townsend M, Nogradi S, Pugsley SO, Keller JL, Newhouse MT. Acute response to bronchodilator: an imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med 1988;148:1949-1952
13. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58:659-664 (Pubitemid 36976273)
14. Wilt TJ, Niewoehner D, Kim CB, et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD): structured abstract. Rockville, MD: Agency for Healthcare Research and Quality, August 2005. (Accessed March 19, 2010, at http://www.ahrq.gov/clinic/tp/spirotp. htm.)
15. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946 (Pubitemid 38807371)
16. Dirksen A, Dijkman JH, Madsen F, et al. A randomized clinical trial of alpha(1)antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468-1472
17. 1: the Lung Health Study. JAMA 1994;272:1497-1505
18. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-239 (Pubitemid 40216240)
19. Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Quick reference guide for clinicians. Rockville, MD: Public Health Service, April 2009.
20. Sin DD, McAlister FA, Man SFP, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003;290:2301-2312 (Pubitemid 37430563)
21. Calverley PMA, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789 (Pubitemid 46294610)
22. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-1554
23. Salpeter SR, Buckley NS, Salpeter EE. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006;21:1011-1019
24. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300:1439-1450 [Erratum, JAMA 2009;301:1227-30.]
25. Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300:2407-2416 [Erratum, JAMA 2009;301:1024.]
26. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-398
27. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1981;1:681-686
28. Górecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52:674-679 (Pubitemid 27404979)
29. Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999;14:1002-1008
30. Bradley JM, O'Neill BM. Short-term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;4:CD004356.
31. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007;176:343-349 (Pubitemid 47267467)
32. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422 (Pubitemid 28242071)
33. 1, decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the Lung Health Study. Am J Respir Crit Care Med 2001;164:358-364
34. Ram FSF, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes NC. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;2:CD004403.
35. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999;340:1941-1947
36. Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003;348:2618-2625
37. McCrory DC, Brown CD. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;4:CD003900.
38. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009. Ann Intern Med 2009;150:40-44
39. Poole PJ, Chacko E, Wood-Baker RWB, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;1:CD002733.
40. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403. (Pubitemid 29111221)
41. Granger RH, Walters JAE, Poole PJ, et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;4:CD001390.
42. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437-2442 (Pubitemid 29526772)
43. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-1755 (Pubitemid 36514705)
44. Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 2008;23:1757-1762
45. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;4:CD003793.
46. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-368
47. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073
48. Stavem K, Bjørtuft Ø, Borgan Ø, Geiran O, Boe J. Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit. J Heart Lung Transplant 2006;25:75-84.
49. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000;117:1146-1161 (Pubitemid 30228377)
50. Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res 2007;9:21-32. (Pubitemid 47009041)
51. Kotz D, Wesseling G, Huibers MJH, van Schayck OCP. Efficacy of confronting smokers with airflow limitation for smoking cessation. Eur Respir J 2009;33:754-762
52. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008;336:598-600. (Pubitemid 351439517)
53. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med 2007;167:551-561 (Pubitemid 46513224)
54. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007;147:633-638 (Pubitemid 351664484)
55. Brooks D, Sottana R, Bell B, et al. Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J 2007;14:87-92.
56. Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med 2007;356:1344-1351 (Pubitemid 46513300)